Shares of Sartorius (OTCMKTS:SARTF – Get Free Report) traded up 7.4% on Tuesday . The company traded as high as $243.86 and last traded at $243.86. Approximately 18 shares changed hands during trading, a decline of 92% from the average daily volume of 223 shares. The stock had previously closed at $227.16.
Sartorius Price Performance
The firm has a market cap of $8.35 billion, a price-to-earnings ratio of 113.42 and a beta of 0.98. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95. The company’s fifty day moving average is $213.39 and its two-hundred day moving average is $216.35.
Sartorius Company Profile
Sartorius AG is a Germany-based life science company that develops and supplies equipment, technologies and services for pharmaceutical, biotechnology and laboratory applications. Its offerings support the development, production and quality control of medicines, vaccines and other biological products.
The company’s products include laboratory instruments, balances, filtration systems, laboratory consumables, bioreactors, cell-culture technologies, fluid-management systems, sensors and analytical equipment.
Read More
- Five stocks we like better than Sartorius
- Microsoft’s 8% Dividend Hike: Confidence Signal or Distraction From Capex Math?
- Paramount Skydance Clears a Major Warner Bros. Discovery Hurdle—Here’s What Comes Next
- Can Apple Overtake NVIDIA as the World’s Most Valuable Company?
- Meta Platforms’ Petal Cable Puts Corning at the Center of AI’s Bandwidth Boom
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.
